Beyond the cholesterol-lowering effect of soy protein: A review of the effects of dietary soy and its constituents on risk factors for cardiovascular disease

Nutrients

Volumn 9, Issue 4, 2017, Pages

  Dan Ramdath, D ^a   Padhi, Emily M T ^a   Sarfaraz, Sidra ^a   Renwick, Simone ^a   Duncan, Alison M ^b  

^a GUELPH RESEARCH AND DEVELOPMENT CENTRE   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cardiovascular disease; Cholesterol; Dietary soy; Functional foods; Isoflavones; Lipids; Obesity; Soy protein

Indexed keywords

C REACTIVE PROTEIN; HYPOCHOLESTEROLEMIC AGENT; ISOFLAVONE; PHOSPHATIDYLCHOLINE; SAPONIN; SOYBEAN PROTEIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL OUTCOME; DIETARY FIBER; ENZYME ACTIVITY; EPIDEMIOLOGY; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMMUNE RESPONSE; INFLAMMATION; INTESTINE FLORA; LIPID BLOOD LEVEL; META ANALYSIS (TOPIC); MORTALITY; MULTICENTER STUDY (TOPIC); NONHUMAN; OBESITY; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SATIETY; SOYBEAN; SYSTEMATIC REVIEW (TOPIC); ANIMAL; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; DIET; DISEASE MODEL; OBSERVATIONAL STUDY;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BIOMARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET; DISEASE MODELS, ANIMAL; HUMANS; ISOFLAVONES; META-ANALYSIS AS TOPIC; OBSERVATIONAL STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SATIATION; SOYBEAN PROTEINS; SOYBEANS; TRIGLYCERIDES;

EID: 85016146111     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9040324     Document Type: Review

References (159)

1. World Health Organization. Global Atlas on Cardiovascular Disease Prevention and Control: Policies, Strategies and Intervention; World Health Organization: Geneva, Switzerland, 2011.
2. Ross, R. Atherosclerosis—An inflammatory disease. N. Engl. J. Med. 1999, 340, 115-126. [CrossRef]
3. Kannel, W.B. Blood pressure as a cardiovascular risk factor: Prevention and treatment. JAMA 1996, 275, 1571-1576. [CrossRef] [PubMed]
4. Duckworth, W.C. Hyperglycemia and cardiovascular disease. Curr. Atheroscler. Rep. 2001, 3, 383-391. [CrossRef] [PubMed]
5. Schulze, P.C.; Lee, R.T. Oxidative stress and atherosclerosis. Curr. Atherscler. Rep. 2005, 7, 242-248. [CrossRef]
6. Bouchenak, M.; Lamri-Senhadji, M. Nutritional quality of legumes, and their role in cardiometabolic risk prevention: A review. J. Med. Food 2013, 16, 185-198. [CrossRef] [PubMed]
7. Mattson, J.W.; Sun, C.; Koo, W.W. Analysis of the World Oil Crops Market. Available online: http://ageconsearch.umn.edu/handle/23621 (accessed on 3 July 2016).
8. Singh, P.; Kumar, R.; Sabapathy, S.N.; Bawa, A.S. Functional and edible uses of soy protein products. CRFSFS 2008, 7, 14-28. [CrossRef]
9. Torres, N.; Torre-Villalvazo, I.; Tovar, A.R. Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J. Nutr. Biochem. 2006, 17, 365-373. [CrossRef] [PubMed]
10. Maki, K.C.; Butteiger, D.N.; Rains, T.M. Effects of soy protein on lipoprotein lipids and fecal bile acid excretion in men and women with moderate hypercholesterolemia. J. Clin. Lipidol. 2010, 4, 531-542. [CrossRef] [PubMed]
11. Anderson, J.W.; Johnston, B.M.; Cook-Newell, M.E. Meta-analysis of the effects of soy-protein intake on serum lipids. N. Engl. J. Med. 1995, 333, 276-282. [CrossRef] [PubMed]
12. Weggemans, R.M.; Trautwein, E.A. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: A meta-analysis. Eur. J. Clin. Nutr. 2003, 57, 940-946. [CrossRef] [PubMed]
13. Yueng, J.; Yu, T.F. Effects of isoflavones (soy phyto-estrogens) on serum lipids: A meta-analysis of randomized controlled trials. Nutr. J. 2003, 2, 1-8. [CrossRef] [PubMed]
14. Zhuo, X.-G.; Melby, M.K.; Watanabe, S. Soy isoflavone intake lowers serum LDL cholesterol: A meta-analysis of 8 randomized controlled trials in humans. J. Nutr. 2004, 134, 2395-2400. [PubMed]
15. Zhan, S.; Ho, S.C. Meta-analysis of the effects of soy-protein containing isoflavones on the lipid profile. Am. J. Clin. Nutr. 2005, 81, 397-408. [PubMed]
16. Reynolds, K.; Chin, A.; Lees, K.A.; Nguyen, A.; Bujnowski, D.; He, J. A meta-analysis of the effect of soy protein supplementation on serum lipids. Am. J. Cardiol. 2006, 98, 633-640. [CrossRef] [PubMed]
17. Taku, K.; Umegaki, K.; Sato, Y.; Taki, Y.; Endoh, K.; Watanabe, S. Soy isoflavones lower serum total and LDL cholesterol in humans: A meta-analysis of 11 randomized controlled trials. Am. J. Clin. Nutr. 2007, 85, 1148-1156. [PubMed]
18. Taku, K.; Umegaki, K.; Ishimi, Y.; Watanabe, S. Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials. Ther. Clin. Risk Manag. 2008, 4, 1097-1103. [CrossRef] [PubMed]
19. Harland, J.I.; Haffner, T.A. Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis 2008, 200, 13-27. [CrossRef] [PubMed]
20. Jenkins, D.J.; Mirrahimi, A.; Srichaikul, K.; Berryman, C.E.; Wang, L.; Carleton, A.; Abdulnour, S.; Sievenpiper, J.L.; Kendall, C.W.; Kris-Etherton, P.M. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J. Nutr. 2010, 140, 2302S-2311S. [CrossRef] [PubMed]
21. Benkhedda, K.; Boudrault, C.; Sinclair, S.E.; Marles, R.J.; Xiao, C.W.; Underhill, L. Health Canada’s proposal to accept a health claim about soy products and cholesterol lowering. Int. Food Risk Anal. J. 2014. [CrossRef]
22. U.S. Food & Drug Administration. Available online: http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/LabelingNutrition/ucm064919.htm(accessed on 28 September 2016).
23. Health Canada: Summary of Health Canada’s Assessment of a Health Claim about Soy Protein and Cholesterol Lowering. Available online: http://www.hc-sc.gc.ca/fn-an/label-etiquet/claims-reclam/ assess-evalu/soy-protein-cholesterol-eng.php (accessed on 28 September 2016).
24. European Food Safety Authority. Scientific Opinion on the Substantiation of a Health Claim Related to Isolated Soy Protein and Reduction of Blood LDL-Cholesterol Concentrations Pursuant to Article 14 of Regulation (EC) No 1924/2006. Available online: http://www.efsa.europa.eu/en/efsajournal/pub/2555 (accessed on 29 January 2017).
25. Dixit, A.K.; Antony, J.I.X.; Sharma, N.K.; Tiwari, R.K. Soybean Constituents and Their Functional Benefits. Opportunity. Available online: http://www.trnres.com/ebook/uploads/tiwari/T_1302158885Tiwari-12.pdf (accessed on 10 January 2017).
26. McCue, P.; Kalidas, S. Health benefits of soy isoflavonoids and strategies for enhancement: A review. Crit. Rev. Food Sci. Nutr. 2004, 44, 361-367. [CrossRef] [PubMed]
27. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747. [PubMed]
28. Hu, X.; Gao, J.; Zhang, Q.; Fu, Y.; Li, K.; Zhu, S.; Li, D. Soy fiber improves weight loss and lipid profile in overweight and obese adults: A randomized controlled trial. Mol. Nutr. Food Res. 2013, 57, 2147-2154. [CrossRef] [PubMed]
29. McGraw, N.J.; Krul, E.S.; Grunz-Borgmann, E.; Parrish, A.R. Soy-based renoprotection. World J. Nephrol. 2016, 5, 233-257. [CrossRef] [PubMed]
30. Omoni, A.O.; Aluko, R.E. Soybean foods and their benefits: Potential mechanisms of action. Nutr. Rev. 2005, 63, 272-283. [CrossRef] [PubMed]
31. Rebholz, C.M.; Friedman, E.E.; Powers, L.J.; Arroyave, W.D.; He, J.; Kelly, T.N. Systematic reviews and metaand pooled analyses dietary protein intake and blood pressure: A meta-analysis of randomized controlled trials. Am. J. Epidemiol. 2012, 176, S27-S43. [CrossRef] [PubMed]
32. Barnes, S.; Prasain, J.; D’Alessandro, T.; Arabshahi, A.; Botting, N.; Lila, M.A.; Jackson, G.; Janle, E.M.; Weaver, C.M. The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems. Food Funct. 2011, 2, 235-244. [CrossRef] [PubMed]
33. Baber, R.J. Phytoestrogens in health: The role of isoflavones. In Isoflavones: Chemistry, Analysis, Function and Effects; Preedy, V.R., Ed.; RSC Publishing: Cambridge, UK, 2011.
34. Shimazu, T.; Kuriyama, S.; Hozawa, A.; Ohmori, K.; Sato, Y.; Nakaya, N.; Nishino, Y.; Tsubono, Y.; Tsuji, I. Dietary patterns and cardiovascular disease mortality in Japan: A prospective cohort study. Int. J. Epidemiol. 2007, 36, 600-609. [CrossRef] [PubMed]
35. Nagata, C.; Wada, K.; Tamura, T.; Konishi, K.; Goto, Y.; Koda, S.; Kawachi, T.; Tsuji, M.; Nakamura, K. Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults: The Takayama study. Am. J. Clin. Nutr. 2016, 105, 426-431. [CrossRef] [PubMed]
36. Reinwald, S.; Akabas, S.R.; Weaver, C.M. Whole versus the piecemeal approach to evaluating soy. J. Nutr. 2010, 140, 2335S-2343S. [CrossRef] [PubMed]
37. Setchell, K.D.R.; Clerici, C. Equol: History, chemistry, and formation. J. Nutr. 2010, 140, 1355S-1362S. [CrossRef] [PubMed]
38. Liu, Z.M.; Ho, S.C.; Chen, Y.M.; Liu, J.; Woo, J. Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women. PLoS ONE 2014, 9, e87861. [CrossRef] [PubMed]
39. Vedrine, N.; Mathey, J.; Morand, C.; Brandolini, M.; Davicco, M.-J.; Guy, L.; Remesy, C.; Coxam, V.; Manach, C. One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women. Eur. J. Clin. Nutr. 2006, 60, 1039-1045. [CrossRef] [PubMed]
40. Vergne, S.; Sauvant, P.; Lamothe, V.; Chantre, P. Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavones. Br. J. Nutr. 2009, 102, 1642-1653. [CrossRef] [PubMed]
41. Yamori, Y.Worldwide epidemic of obesity: Hope for Japanese diets. Clin. Exp. Pharmacol. Physiol. 2004, 31, 2-4. [CrossRef] [PubMed]
42. Wu, S.H.; Shu, X.O.; Chow, W.H.; Xiang, Y.B.; Zhang, X.; Li, H.L.; Cai, Q.; Ji, B.; Cai, H.; Rothman, N., et al. Soy food intake and circulating levels of inflammatory markers in Chinese women. J. Acad. Nutr. Diet. 2013, 112, 996-1004. [CrossRef] [PubMed]
43. Borgi, L.; Muraki, I.; Satija, A.; Willett, W.C.; Rimm, E.B.; Forman, J.P. Fruit and vegetable consumption and the incidence of hypertension in three prospective cohort studies. Hypertension 2016, 67, 288-293. [CrossRef] [PubMed]
44. Golzarand, M.; Bahadoran, Z.; Mirmiran, P.; Sadeghian-Sharif, S.; Azizi, F. Dietary phytochemical index is inversely associated with the occurrence of hypertension in adults: A 3-year follow-up (the Tehran Lipid and Glucose Study). Eur. J. Clin. Nutr. 2015, 69, 392-398. [CrossRef] [PubMed]
45. Tatsumi, Y.; Morimoto, A.; Deura, K.; Mizuno, S.; Ohno, Y.; Watanabe, S. Effects of soybean product intake on fasting and postload hyperglycemia and type 2 diabetes in Japanese men with high body mass index: The Saku Study. J. Diabetes Investig. 2013, 4, 626-633. [CrossRef] [PubMed]
46. Nanri, A.; Mizoue, T.; Takahashi, Y.; Kirii, K.; Inoue, M.; Noda, M.; Tsugane, S. Soy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese women. J. Nutr. 2010, 140, 580-586. [PubMed]
47. Mueller, N.T.; Odegaard, A.O.; Gross, M.D.; Koh, W.P.; Mimi, C.Y.; Yuan, J.M.; Pereira, M.A. Soy intake and risk of type 2 diabetes mellitus in Chinese Singaporeans. Eur. J. Nutr. 2012, 51, 1033-1040. [CrossRef] [PubMed]
48. Ding, M.; Pan, A.; Manson, J.E.; Willett, W.C.; Malik, V.; Rosner, B.; Giovannucci, E.; Hu, F.B.; Sun, Q. Consumption of soy foods and isoflavones and risk of type 2 diabetes: A pooled analysis of three US cohorts. Eur. J. Clin. Nutr. 2016, 70, 1381-1387. [CrossRef] [PubMed]
49. Morimoto, Y.; Steinbrehcer, A.; Kolonel, L.; Maskarinec, G. Soy consumption is not protective against diabetes in Hawaii: The multiethnic cohort. Eur. J. Clin. Nutr. 2011, 65, 279-282. [CrossRef] [PubMed]
50. Lou, D.; Li, Y.; Yan, G.; Bu, J.; Wang, H. Soy consumption with risk of coronary heart disease and stroke: A meta-analysis of observational studies. Neuroepidemiology 2016, 46, 242-252. [CrossRef] [PubMed]
51. Pujol, T.J.; Tucker, J.E. Diseases of the cardiovascular system. In Nutrition Therapy and Pathophysiology; Nelms, M., Sucher, K., Long, S., Eds.; Thomson Brooks/Cole: Belmont, CA, USA, 2007; pp. 371-415.
52. Tanira, M.O.; Al Balushi, K.A. Genetic variations related to hypertension: A review. J. Hum. Hypertens. 2005, 19, 7-19. [CrossRef] [PubMed]
53. Jackson, R.L.; Greiwe, J.S.; Schwen, R.J. Emerging evidence of the health benefits of S-equol, an estrogen receptor β-agonist. Nutr. Rev. 2011, 69, 432-448. [CrossRef] [PubMed]
54. Colacurci, N.; Chiantera, A.; Fornaro, F.; de Novellis, V.; Manzella, D.; Arciello, A.; Chiantera, V.; Improta, L.; Paolisso, G. Effects of soy isoflavones on endothelial function in healthy postmenopausal women. Menopause 2005, 12, 299-307. [CrossRef] [PubMed]
55. Patten, G.S.; Abeywardena, M.Y.; Bennett, L.E. Inhibition of angiotensin converting enzyme, angiotensin II receptor blocking, and blood pressure lowering bioactivity across plant families. Crit. Rev. Food Sci. Nutr. 2016, 56, 181-214. [CrossRef] [PubMed]
56. Taku, K.; Lin, N.; Cai, D.; Hu, J.; Zhao, X.; Zhang, Y.; Wang, P.; Melby, M.K.; Hooper, L.; Kurzer, M.S., et al. Effects of soy isoflavone extract supplements on blood pressure in adult humans: Systematic review and meta-analysis of randomized placebo-controlled trials. J. Hypertens. 2010, 28, 1971-1982. [CrossRef] [PubMed]
57. Liu, X.X.; Li, S.H.; Chen, J.Z.; Sun, K.; Wang, X.J.; Wang, X.G.; Hui, R.T. Effect of soy isoflavones on blood pressure: A meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 2012, 22, 463-470. [CrossRef] [PubMed]
58. Garcia Garcia, M.A.; Arenas, R.; Martinez, C.A.; Perez, L.L. Usefulness of phytoestrogens in treatment of arterial hypertension: Systematic review and meta-analysis. Arch. Clin. Hypertens. 2016, 1, 29-34.
59. Hügel, H.M.; Jackson, N.; May, B.; Zhang, A.L.; Xue, C.C. Polyphenol protection and treatment of hypertension. Phytomedicine 2016, 23, 220-231. [CrossRef] [PubMed]
60. Hazim, S.; Curtis, P.J.; Schär, M.Y.; Ostertag, L.M.; Kay, C.D.; Minihane, A.-M.; Cassidy, A. Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: A double-blind randomized controlled trial. Am. J. Clin. Nutr. 2016, 103, 694-702. [CrossRef] [PubMed]
61. Acharjee, S.; Zhou, J.; Elajami, T.K.; Welty, F.K. Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status. Metabolism 2015, 64, 236-243. [CrossRef] [PubMed]
62. Liu, Z.; Ho, S.C.; Chen, Y.; Tomlinson, B.; Ho, S.; To, K.; Woo, J. Effect of whole soy and purified daidzein on ambulatory blood pressure and endothelial function—A 6-month double-blind, randomized controlled trial among Chinese postmenopausal women with prehypertension. Eur. J. Clin. Nutr. 2015, 69, 1161-1168. [CrossRef] [PubMed]
63. Nishibori, N.; Kishibuchi, R.; Morita, K. Soy pulp extract inhibits angiotensin I-converting enzyme (ACE) activity in vitro: Evidence for its potential hypertension-improving action. J. Diet. Suppl. 2017, 14, 241-251. [CrossRef] [PubMed]
64. Van der Kuil, W.A.; Engberink, M.F.; Brink, E.J.; van Baak, M.A.; Bakker, S.J.L.; Navis, G.; van’t Veer, P.; Geleijnse, J.M. Dietary protein and blood pressure: A systematic review. PLoS ONE 2010, 5, e12102. [CrossRef] [PubMed]
65. Liu, Z.M.; Ho, S.C.; Chen, Y.M.; Woo, J. Effect of soy protein and isoflavones on blood pressure and endothelial cytokines: A 6-month randomized controlled trial among postmenopausal women. J. Hypertens. 2013, 31, 382-392. [CrossRef] [PubMed]
66. Welty, F.K.; Lee, K.S.; Lew, N.S.; Zhou, J.R. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch. Intern. Med. 2007, 167, 1060-1067. [CrossRef] [PubMed]
67. Zang, Y.; Zhang, L.; Igarashi, K.; Yu, C. The anti-obesity and anti-diabetic effects of kaempferol glycosides from unripe soybean leaves in high-fat-diet mice. Food Funct. 2015, 6, 834-841. [CrossRef] [PubMed]
68. Mohammadifard, N.; Salehi-Abargouei, A.; Salas-Salvadó, J.; Guasch-Ferré, M.; Humphries, K.; Sarrafzadegan, N. The effect of tree nut, peanut, and soy nut consumption on blood pressure: A systematic review and meta-analysis of randomized controlled clinical trials. Am. J. Clin. Nutr. 2015, 101, 966-982. [CrossRef] [PubMed]
69. Moghaddam, A.S.; Entezari, M.H.; Iraj, B.; Gholamreza, A.; Zahabi, E.S.; Maracy, M.R. The effects of soy bean flour enriched bread intake on anthropometric indices and blood pressure in type 2 diabetic women: A crossover randomized controlled clinical trial. Int. J. Endocrinol. 2014, 2014, 240760. [CrossRef] [PubMed]
70. Evans, M.; Njike, V.Y.; Hoxley, M.; Pearson, M.; Katz, D.L. Effect of soy isoflavone protein and soy lecithin on endothelial function in healthy postmenopausal women. Menopause 2007, 14, 141-149. [CrossRef] [PubMed]
71. Moncada, S.; Higgs, A. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 1993, 329, 2002-2012. [PubMed]
72. Dong, J.-Y.; Qin, L.-Q.; Zhang, Z.; Zhao, Y.; Wang, J.; Arigoni, F.; Zhang, W. Effect of oral L-arginine supplementation on blood pressure: A meta-analysis of randomized, double-blind, placebo-controlled trials. Am. Heart J. 2011, 162, 959-965. [CrossRef] [PubMed]
73. Bai, Y.; Sun, L.; Yang, T.; Sun, K.; Chen, J.; Hui, R. Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: Meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2009, 89, 77-84. [CrossRef] [PubMed]
74. Vasdev, S.; Gill, V. The antihypertensive effect of arginine. Int. J. Angiol. 2008, 17, 7-22. [CrossRef] [PubMed]
75. United States Department of Agriculture Agricultural Research Service: USDA Food Composition Databases. Available online: https://ndb.nal.usda.gov/ndb/search/list (accessed on 1 March 2017).
76. Sarwar, G.; McDonough, F.E. Evaluation of protein digestibility-corrected amino acid score method for assessing protein quality of foods. J. Assoc. Off. Anal. Chem. 1990, 73, 347-356. [PubMed]
77. Hughes, G.J.; Ryan, D.J.; Mukherjea, R.; Schasteen, C.S. Protein digestibility-corrected amino acid scores (PDCAAS) for soy protein isolates and concentrate: Criteria for evaluation. J. Agric. Food Chem. 2011, 59, 12707-12712. [CrossRef] [PubMed]
78. Ahrens, S.; Venkatachalam, M.; Mistry, A.M.; Lapsley, K.; Sathe, S.K. Almond (Prunus dulcis L.) protein quality. Plant Foods Hum. Nutr. 2005, 60, 123-128. [CrossRef] [PubMed]
79. Hoffman, J.R.; Falvo, M.J. Protein-which is best? J. Sports Sci. Med. 2004, 3, 118-130. [PubMed]
80. World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation; World Health Organization: Geneva, Switzerland, 2006.
81. Younis, N.; Charlton-Menys, V.; Sharma, R.; Soran, H.; Durrington, P.N. Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro. Atherosclerosis 2009, 202, 162-168. [CrossRef] [PubMed]
82. Yang, W.; Wang, S.; Li, L.; Liang, Z.; Wang, L. Genistein reduces hyperglycemia and islet cell loss in a high-dosage manner in rats with alloxan-induced pancreatic damage. Pancreas 2011, 40, 396-402. [CrossRef] [PubMed]
83. Fu, Z.; Gilbert, E.R.; Pfeiffer, L.; Zhang, Y.; Fu, Y.; Liu, D. Genistein ameliorates hyperglycemia in a mouse model of nongenetic type 2 diabetes. Appl. Physiol. Nutr. Metab. 2012, 37, 480-488. [CrossRef] [PubMed]
84. Harini, R.; Ezhumalai, M.; Pugalendi, K.V. Antihyperglycemic effect of biochanin A, a soy isoflavone, on streptozotocin-diabetic rats. Eur. J. Pharmacol. 2012, 676, 89-94. [CrossRef] [PubMed]
85. Gilbert, E.R.; Liu, D. Anti-diabetic functions of soy isoflavone genistein: Mechanisms underlying effects on pancreatic β-cell function. Food Funct. 2013, 4, 200-212. [CrossRef] [PubMed]
86. Ademiluyi, A.O.; Oboh, G. Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro. Exp. Toxicol. Pathol. 2013, 65, 305-309. [CrossRef] [PubMed]
87. Squadrito, F.; Marini, H.; Bitto, A.; Altavilla, D.; Polito, F.; Adamo, E.B.; D’Anna, R.; Arcoraci, V.; Burnett, B.P.; Minutoli, L., et al. Genistein in the metabolic syndrome: Results of a randomized clinical trial. J. Clin. Endocrinol. Metab. 2013, 98, 3366-3374. [CrossRef] [PubMed]
88. Ho, S.C.; Chen, Y.M.; Ho, S.S.; Woo, J.L. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: A double-blind, randomized, placebo-controlled trial. Menopause 2007, 14, 905-912. [CrossRef] [PubMed]
89. Atteritano, M.; Marini, H.; Minutoli, L.; Polito, F.; Bitto, A.; Altavilla, D.; Mazzaferro, S.; D’Anna, R.; Cannata, M.L.; Gaudio, A., et al. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 2007, 92, 3068-3075. [CrossRef] [PubMed]
90. Liu, Z.M.; Chen, Y.M.; Ho, S.C.; Ho, Y.P.; Woo, J. Effects of soy protein and isoflavones on glycemic control and insulin sensitivity: A 6-month, randomized, placebo-controlled trial in postmenopausal Chinese women with prediabetes or untreated early diabetes. Am. J. Clin. Nutr. 2010, 91, 1394-1401. [CrossRef] [PubMed]
91. Ye, Y.B.; Chen, A.L.; Lu, W.; Zhuo, S.Y.; Liu, J.; Guan, J.H.; Deng, W.P.; Fang, S.; Li, Y.B.; Chen, Y.M. Daidzein and genistein fail to improve glycemic control and insulin sensitivity in Chinese women with impaired glucose regulation: A double-blind, randomized, placebo-controlled trial. Mol. Nutr. Food Res. 2015, 59, 240-249. [CrossRef] [PubMed]
92. Ricci, E.; Cipriani, S.; Chiaffarino, F.; Malvezzi, M.; Parazzini, F. Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women: A meta-analysis of randomized controlled trials. Menopause 2010, 17, 1080-1086. [CrossRef] [PubMed]
93. Fang, K.; Dong, H.; Wang, D.; Gong, J.; Huang, W.; Lu, F. Soy isoflavones and glucose metabolism in menopausal women: A systematic review and meta-analysis of randomized controlled trials. Mol. Nutr. Food Res. 2016, 60, 1602-1614. [CrossRef] [PubMed]
94. Zhang, X.; Zhang, Y.; Chi, M. Soy protein supplementation reduces clinical indices in type 2 diabetes and metabolic syndrome. Yonsei Med. J. 2016, 57, 681-689. [CrossRef] [PubMed]
95. Liu, Z.M.; Chen, Y.M.; Ho, S.C. Effects of soy intake on glycemic control: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2011, 93, 1092-1101. [CrossRef] [PubMed]
96. Bakhtiary, A.; Yassin, Z.; Hanachi, P.; Rahmat, A.; Ahmad, Z.; Halalkhor, S.; Firouzjahi, A.R. Evaluation of the Oxidative Stress and Glycemic Control Status in Response to Soy in OlderWomen with the Metabolic Syndrome. Iran. Red Crescent Med. J. 2011, 13, 795-804.
97. Azadbakht, L.; Kimiagar, M.; Mehrabi, Y.; Esmaillzadeh, A.; Padyab, M.; Hu, F.B.; Willett, W.C. Soy inclusion in the diet improves features of the metabolic syndrome: A randomized crossover study in postmenopausal. Am. J. Clin. Nutr. 2007, 85, 735-741. [PubMed]
98. Urita, Y.; Noda, T.; Watanabe, D.; Iwashita, S.O.H.; Hamada, K.; Sugimoto, M. Effects of a soybean nutrition bar on the postprandial blood glucose and lipid levels in patients with diabetes mellitus. Int. J. Food Sci. Nutr. 2012, 63, 921-929. [CrossRef] [PubMed]
99. Oku, T.; Nakamura, M.; Takasugi, A. Effects of cake made from whole soy powder on postprandial blood glucose and insulin levels in human subjects. Int. J. Food Sci. Nutr. 2009, 60, 224-231. [CrossRef] [PubMed]
100. Liu, C.; Lin, X.L.; Wan, Z.; Zou, Y.; Cheng, F.F.; Yang, X.Q. The physicochemical properties, in vitro binding capacities and in vivo hypocholesterolemic activity of soluble dietary fiber extracted from soy hulls. Food Funct. 2016, 7, 4830-4840. [CrossRef] [PubMed]
101. Au, M.M.C.; Goff, D.; Kisch, J.A.; Coulson, A.; Wright, A.J. Effects of soy-soluble fiber and flaxseed gum on the glycemic and insulinemic responses to glucose solutions and dairy products in healthy adult males. J. Am. Coll. Nutr. 2013, 32, 98-110. [CrossRef] [PubMed]
102. Tokede, O.A.; Onabanjo, T.A.; Yansane, A.; Gaziano, J.M.; Djoussé, L. Soya products and serum lipids: A meta-analysis of randomised controlled trials. Br. J. Nutr. 2015, 114, 831-943. [CrossRef] [PubMed]
103. Marino, M.; Galluzzo, P.; Ascenzi, P. Estrogen signaling multiple pathways to impact gene transcription. Curr. Genom. 2006, 7, 497-508. [CrossRef]
104. Ricketts, M.-L.; Moore, D.D.; Banz, W.J.; Mezei, O.; Shay, N.F. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. J. Nutr. Biochem. 2005, 16, 321-330. [CrossRef] [PubMed]
105. Engelbert, A.K.; Soukup, S.T.; Roth, A.; Hoffmann, N.; Graf, D.; Watzl, B.; Kulling, S.E.; Bub, A. Isoflavone supplementation in postmenopausal women does not affect leukocyte LDL receptor and scavenger receptor CD36 expression: A double-blind, randomized, placebo-controlled trial. Mol. Nutr. Food Res. 2016, 60, 2008-2019. [CrossRef] [PubMed]
106. Turner, R.; Baron, T.; Wolffram, S.; Minihane, A.M.; Cassidy, A.; Rimbach, G.; Weinberg, P.D. Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radic. Res. 2004, 38, 209-216. [CrossRef] [PubMed]
107. Xiao, C.W.; Wood, C.M.; Weber, D.; Aziz, S.A.; Mehta, R.; Griffin, P.; Cockell, K.A. Dietary supplementation with soy isoflavones or replacement with soy proteins prevents hepatic lipid droplet accumulation and alters expression of genes involved in lipid metabolism in rats. Genes Nutr. 2014, 9, 373. [CrossRef] [PubMed]
108. Kobayashi, M.; Egusa, S.; Fukuda, M. Isoflavone and protein constituents of lactic acid-fermented soy milk combine to prevent dyslipidemia in rats fed a high cholesterol diet. Nutrients 2014, 6, 5704-5723. [CrossRef] [PubMed]
109. Yang, B.; Chen, Y.; Xu, T.C.; Yu, Y.H.; Huang, T.; Hu, X.J.; Li, D. Systematic review and meta-analysis of soy products consumption in patients with type 2 diabetes mellitus. Asia Pac. J. Clin. Nutr. 2011, 20, 593-602. [PubMed]
110. Huang, H.; Xie, Z.; Boue, S.M.; Bhatnagar, D.; Yokoyama, W.; Yu, L.; Wang, T.T.Y. CZolesterol-lowering activity of soy-derived glyceollins in the golden Syrian hamster model. J. Agric. Food Chem. 2013, 61, 5772-5782. [CrossRef] [PubMed]
111. Nagata, Y.; Yamasaki, S.; Torisu, N.; Suzuki, T.; Shimamoto, S.; Tamaru, S.; Tanaka, K. Okara, a by-product of tofu manufacturing, modifies triglyceride metabolism at the intestinal and hepatic levels. J. Nutr. Sci. Vitaminol. 2016, 62, 162-169. [CrossRef] [PubMed]
112. Sahebkar, A. Fat lowers fat: Purified phospholipids as emerging therapies for dyslipidemia. Biochem. Biophys. Acta-Mol. Cell Biol. Lipids 2013, 1831, 887-893. [CrossRef] [PubMed]
113. Ovesen, L.; Ebbesen, K.; Olesen, E.S. The Effects of oral soybean phospholipid on serum total cholesterol, plasma triglyceride, and serum high-density lipoprotein cholesterol concentrations in hyperlipidemia. J. Parent. Enter. Nutr. 1985, 9, 716-719. [CrossRef] [PubMed]
114. Spilburg, F.; Goldberg, A.C.; McGill, J.B.; Stenson, W.F.; Racette, S.B.; Bateman, J.; McPherson, T.B.; Ostlun, R.E., Jr. Fat-free foods supplemented with soy stanol-lecithin powder reduce cholesterol absorption and LDL cholesterol. J. Am. Diet. Assoc. 2003, 103, 577-581. [CrossRef] [PubMed]
115. Høie, L.H.; Morgenstern, E.C.; Gruenwald, J.; Graubaum, H.J.; Busch, R.; Lüder, W.; Zunft, H.J. A double-blind placebo-controlled clinical trial compares the cholesterol-lowering effects of two different soy protein preparations in hypercholesterolemic subjects. Eur. J. Nutr. 2005, 44, 65-71. [CrossRef] [PubMed]
116. Lukaczer, D.; Liska, D.J.; Lerman, R.H.; Darland, G.; Schilz, B.; Tripp, M.; Bland, J.S. Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women. Nutrition 2006, 22, 104-113. [CrossRef] [PubMed]
117. Dong, S.; Zhang, R.; Ji, Y.; Hao, J.Y.; Ma, W.W.; Chen, X.D.; Xiao, R.; Yu, H.L. Soy milk powder supplemented with phytosterol esters reduced serum cholesterol level in hypercholesterolemia independently of lipoprotein E genotype: A random clinical placebo-controlled trial. Nutr. Res. 2016, 36, 879-884. [CrossRef] [PubMed]
118. Butteiger, D.N.; Hibberd, A.A.; McGraw, N.J.; Napawan, N.; Hall-Porter, J.M.; Krul, E.S. Soy protein compared with milk protein in a western diet increases gut microbial diversity and reduces serum lipids in golden Syrian hamsters. J. Nutr. 2016, 146, 697-705.
119. Libby, P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr. 2006, 83, 456S-460S. [PubMed]
120. Han, S.; Wu, H.; Li, W.; Gao, P. Protective effects of genistein in homocysteine-induced endothelial cell inflammatory injury. Mol. Cell. Biochem. 2015, 403, 43-49. [CrossRef] [PubMed]
121. Hernandez-Montes, E.; Pollard, S.E.; Vauzour, D.; Jofre-Montseny, L.; Rota, C.; Rimbach, G.; Weinberg, P.D.; Spencer, J.P.E. Activation of glutathione peroxidase via Nrf1 mediates genistein’s protection against oxidative endothelial cell injury. Biochem. Biophys. Res. Commun. 2006, 346, 851-859. [CrossRef] [PubMed]
122. Sakamoto, Y.; Kanatsu, J.; Toh, M.; Naka, A.; Kondo, K.; Iida, K. The dietary isoflavone daidzein reduces expression of pro-inflammatory genes through PPARα/γ and JNK pathways in adipocyte and macrophage co-cultures. PLoS ONE 2016, 11, e0149676. [CrossRef] [PubMed]
123. Lesinski, G.B.; Reville, P.K.; Mace, T.A.; Young, G.S.; Ahn-Jarvis, J.; Thomas-Ahner, J.; Vodovotz, Y.; Ameen, Z.; Grainger, E.; Riedl, K., et al. Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells. Cancer Prev. Res. 2015, 8, 1036-1044. [CrossRef] [PubMed]
124. Ferguson, J.F.; Ryan, M.F.; Gibney, E.R.; Brennan, L.; Roche, H.M.; Reilly, M.P. Dietary isoflavone intake is associated with evoked responses to inflammatory cardiometabolic stimuli and improved glucose homeostasis in healthy volunteers. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 996-1003. [CrossRef] [PubMed]
125. Llaneza, P.; González, C.; Fernandez-Iñarrea, J.; Alonso, A.; Diaz, F.; Arnott, I.; Ferrer-Barriendos, J. Soy isoflavones, diet and physical exercise modify serum cytokines in healthy obese postmenopausal women. Phytomedicine 2011, 18, 245-250. [CrossRef] [PubMed]
126. Azadbakht, L.; Atabak, S.; Esmaillzadeh, A. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes. Diabetes Care 2008, 31, 648-654. [CrossRef] [PubMed]
127. Tomayko, E.J.; Kistler, B.M.; Fitschen, P.J.; Wilund, K.R. Intradialytic protein supplementation reduces inflammation and improves physical function in maintenance hemodialysis patients. J. Ren. Nutr. 2015, 25, 276-283. [CrossRef] [PubMed]
128. Reverri, E.J.; LaSalle, C.D.; Franke, A.A.; Steinberg, F.M. Soy provides modest benefits on endothelial function without affecting inflammatory biomarkers in adults at cardiometabolic risk. Mol. Nutr. Food Res. 2015, 59, 323-332. [CrossRef] [PubMed]
129. Nakamura, H.; Takasawa, M.; Kashara, S.; Tsuda, A.; Momotsu, T.; Ito, S.; Shibata, A. Effects of acute protein loads of different sources on renal function of patients with diabetic nephropathy. Tohoku J. Exp. Med. 1989, 159, 153-162. [CrossRef] [PubMed]
130. Mauriz, J.L.; Matilla, B.; Culebras, J.M.; Gonzalez, P.; Gonzalez-Gallego, J. Dietary glycine inhibits activation of nuclear factor kappa B and prevents liver injury in hemorrhagic shock in the rat. Free Radic. Biol. Med. 2001, 31, 1236-1244. [CrossRef]
131. DeBoer, M.D. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: A need for screening tools to target interventions. Nutrition 2013, 29, 379-386. [CrossRef] [PubMed]
132. Furukawa, S.; Fujita, T.; Shimabukuro, M.; Iwaki, M.; Yamada, Y.; Nakajima, Y.; Nakayama, O.; Makishima, M. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 2004, 114, 1252-1261. [CrossRef] [PubMed]
133. Chaiswing, L.; Cole, M.P.; St. Clair D.K., Ittarat, W.; Szweda, L.I.; Oberley, T.D. Oxidative damage precedes nitrative damage in adriamycin-induced cardiac mitochondrial injury. Toxicol. Pathol. 2004, 32, 536-547. [PubMed]
134. Kurrat, A.; Blei, T.; Kluxen, F.M.; Mueller, D.R.; Piechotta, M.; Soukup, S.T.; Kulling, S.E.; Diel, P. Lifelong exposure to dietary isoflavones reduces risk of obesity in ovariectomizedWistar rats. Mol. Nutr. Food Res. 2015, 59, 2407-2418. [CrossRef] [PubMed]
135. Huang, C.; Pang, D.; Luo, Q.; Chen, X.; Gao, Q.; Shi, L.; Liu, W.; Zou, Y.; Li, L.; Chen, Z. Soy Isoflavones regulate lipid metabolism through an AKT/mTORC1 pathway in diet-induced obesity (DIO) male rats. Molecules 2016, 21, 586. [CrossRef] [PubMed]
136. Yang, H.; Li, F.; Xiong, X.; Kong, X.; Zhang, B.; Yuan, X.; Fan, J.; Duan, Y.; Geng, M.; Li, L., et al. Soy isoflavones modulate adipokines and myokines to regulate lipid metabolism in adipose tissue, skeletal muscle and liver of male Huanjiang mini-pigs. Mol. Cell. Endocrinol. 2013, 365, 44-51. [CrossRef] [PubMed]
137. Rupasinghe, H.P.V.; Sekhon-Loodu, S.; Mantso, T.; Panayiotidis, M.I. Phytochemicals in regulating fatty acid β-oxidation: Potential underlying mechanisms and their involvement in obesity and weight loss. Pharmacol. Ther. 2016, 165, 153-163. [CrossRef] [PubMed]
138. Zanella, I.; Marrazzo, E.; Biasiotto, G.; Penza, M.; Romani, A.; Vignolini, P.; Caimi, L.; Di Lorenzo, D. Soy and the soy isoflavone genistein promote adipose tissue development in male mice on a low-fat diet. Eur. J. Nutr. 2015, 54, 1095-1107. [CrossRef] [PubMed]
139. Giordano, E.; Dávalos, A.; Crespo, M.C.; Tomé-Carneiro, J.; Gómez-Coronado, D.; ViZioli, F. Soy isoflavones in nutritionally relevant amounts have varied nutrigenomic effects on adipose tissue. Molecules 2015, 20, 2310-2322. [CrossRef] [PubMed]
140. Oh, H.-G.; Kang, Y.-R.; Lee, H.-Y.; Kim, J.-H.; Shin, E.-H.; Lee, B.-G.; Park, S.-H.; Moon, D.-I.; Kim, O.-J.; Lee, I.A., et al. Ameliorative effects of Monascus pilosus-fermented black soybean (Glycine max L. Merrill) on high-fat diet-induced obesity. J. Med. Food 2014, 17, 972-978. [CrossRef] [PubMed]
141. Wu, J.; Oka, J.; Tabata, I.; Higuchi, M.; Toda, T.; Fuku, N.; Ezaki, J.; Sugiyama, F.; Uchiyama, S.; Yamada, K., et al. Effects of isoflavone and exercise on BMD and fat mass in postmenopausal Japanese women: A 1-year randomized placebo-controlled trial. J. Bone Miner. Res. 2006, 21, 780-789. [CrossRef] [PubMed]
142. Matvienko, O.A.; Alekel, D.L.; Genschel, U.; Ritland, L.; Van Loan, M.D.; Koehler, K.J. Appetitive hormones, but not isoflavone tablets, influence overall and central adiposity in healthy postmenopausal women. Menopause 2010, 17, 594-601. [CrossRef] [PubMed]
143. Frankenfeld, C.L.; Atkinson, C.; Wähälä, K.; Lampe, J.W. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein. Eur. J. Clin. Nutr. 2014, 68, 526-530. [CrossRef] [PubMed]
144. Kani, A.H.; Alavian, S.M.; Esmaillzadeh, A.; Adibi, P.; Azadbakht, L. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial. Nutrition 2014, 30, 814-821. [CrossRef] [PubMed]
145. Suga, Y.; Tanabe, K.; Kim, J.; Sato, H.; Iwashita, S.; Hamada, K.; Kuno, S. A comparison of the influences of soy-vs. wheat-based supplements on weight loss in middle-aged subjects. Int. J. Sport Health Sci. 2013, 11, 10-19. [CrossRef]
146. Beavers, K.M.; Gordon, M.M.; Easter, L.; Beavers, D.P.; Hairston, K.G.; Nicklas, B.J.; Vitolins, M.Z. Effect of protein source during weight loss on body composition, cardiometabolic risk and physical performance in abdominally obese, older adults: A pilot feeding study. J. Nutr. Health Aging 2015, 19, 87-95. [CrossRef] [PubMed]
147. Takahira, M.; Noda, K.; Fukushima, M.; Zhang, B.; Mitsutake, R.; Uehara, Y.; Ogawa, M.; Kakuma, T.; Saku, K. Randomized, double-blind, controlled, comparative trial of formula food containing soy protein vs. milk protein in visceral fat obesity. Circ. J. 2011, 75, 2235-2243. [PubMed]
148. Kok, L.; Kreijkamp-Kaspers, S.; Grobbee, D.E.; Lampe, J.W.; van der Schouw, Y.T. Soy isoflavones, body composition, and physical performance. Maturitas 2005, 16, 102-110. [CrossRef] [PubMed]
149. Kwak, J.H.; Ahn, C.W.; Park, S.H.; Jung, S.U.; Min, B.J.; Kim, O.Y.; Lee, J.H. Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: Double blind, randomized, controlled study. Food Funct. 2012, 3, 1019-1024. [CrossRef] [PubMed]
150. Koohkan, S.; Schaffner, D.; Milliron, B.J.; Frey, I.; König, D.; Deibert, P.; Vitolins, M.; Berg, A. The impact of a weight reduction program with and without meal-replacement on health related quality of life in middle-aged obese females. BMC Womens Health 2014, 14, 45. [CrossRef] [PubMed]
151. Weickert, M.O.; Reimann, M.; Otto, B.; Hall, W.L.; Vafeiadou, K.; Hallund, J.; Ferrari, M.; Talbot, D.; Branca, F.; Bügel, S., et al. Soy isoflavones increase preprandial peptide YY (PYY), but have no effect on ghrelin and body weight in healthy postmenopausal women. J. Negat. Results Biomed. 2006, 5, 1-6. [CrossRef] [PubMed]
152. Simmons, A.L.; Miller, C.K.; Clinton, S.K.; Vodovot, Y. A comparison of satiety, glycemic index, and insulinemic index of wheat-derived soft pretzels with or without soy. Food Funct. 2011, 2, 678-683. [CrossRef] [PubMed]
153. Douglas, S.M.; Lasley, T.R.; Leidy, H.J. Consuming beef vs. soy protein has little effect on appetite, satiety, and food intake in healthy Adults. J. Nutr. 2015, 145, 1010-1016. [CrossRef] [PubMed]
154. Neacsu, M.; Fyfe, C.; Horgan, G.; Johnstone, A.M. Appetite control and biomarkers of satiety with vegetarian (soy) and meat-based high-protein diets for weight loss in obese men: A randomized crossover trial. Am. J. Clin. Nutr. 2014, 100, 548-558. [CrossRef] [PubMed]
155. Tahavorgar, A.; Vafa, M.; Shidfar, F.; Gohari, M.; Heydari, I. Whey protein preloads are more beneficial than soy protein preloads in regulating appetite, calorie intake, anthropometry, and body composition of overweight and obese men. Nutr. Res. 2014, 34, 856-861. [CrossRef] [PubMed]
156. Padhi, E.M.T.; Ramdath, D.D.; Carson, S.J.; Hawke, A.; Blewett, H.J.; Wolever, T.M.S.; Vella, D.; Seetharaman, K.; Duizer, L.M.; Duncan, A.M. Liking of soy flour muffins over time and the impact of a health claim on willingness to consume. Food Res. Int. 2015, 77, 491-497. [CrossRef]
157. Leidy, H.J.; Todd, C.B.; Zino, A.Z.; Immel, J.E.; Mukherjea, R.; Shafer, R.S.; Ortinau, L.C.; Braun, M. Consuming high-protein soy snacks affects appetite control, satiety, and diet quality in young people and influences select aspects of mood and cognition. J. Nutr. 2015, 145, 1614-1622. [CrossRef] [PubMed]
158. König, D.; Muser, K.; Berg, A.; Deibert, P. Fuel selection and appetite-regulating hormones after intake of a soy protein-based meal replacement. Nutrition 2012, 28, 35-39. [CrossRef] [PubMed]
159. Huang, X.F.; Liu, H.; Rahardjo, G.L.; Mclennan, P.L.; Tapsell, L.C.; Buttemer, W.A. Effects of diets high in whey, soy, red meat and milk protein on body weight maintenance in diet-induced obesity in mice. Nutr. Diet. 2008, 65, S53-S59. [CrossRef]